HealthTree University: Autologous Stem Cell Transplant (Part 1 of 3)
Posted: Oct 08, 2020
HealthTree University: Autologous Stem Cell Transplant (Part 1 of 3) image

Autologous Stem Cell Transplant (ASCT) is a myeloma treatment that has stood the test of time, because it is widely considered safe and effective for a wide range of myeloma patients. Many consider a transplant as their first myeloma therapy, and those who don’t will probably still want to have the option later to do one. This series, taught by world experts on ASCT for multiple myeloma patients was created to teach you the ins and outs of ASCT to help you make the best decision for your best outcomes.

Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. We invite you to watch these, and also visit HealthTree University and creating a HealthTree account. By creating a HealthTree account, in HealthTree University you can:

  • Save and keep track of your progress in the courses
  • Get points for answering quiz questions
  • Bookmark videos
  • Take notes
  • Earn prizes [COMING SOON]
  • And get access to all the other incredible features of HealthTree!

 

Join HealthTree

 

7.01 - What are the different types of stem cell transplants?

 

7.02 - What is an ASCT (autologous stem cell transplant)? Why is it effective? Is it safe?

 

7.03 - Who should consider an ASCT?

 

7.04 - Why consider an ASCT in the age of novel therapies?

 

7.05 - At what point in treatment should ASCT be considered, and is there a best time to have an ASCT?

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Amrita Krishnan, MD of City of Hope
  • Aravind Ramakrishnan, MD of St. David's South Austin Medical Center
  • Parameswaran Hari, MD, MRCP of Medical College of Wisconsin
  • Aaron Rapoport, MD of University of Maryland
  • Saad Usmani, MD, FACP of Levine Cancer Institute
  • Omar Nadeem, MD of Dana-Farber Cancer Institute
  • Philip McCarthy, MD of Roswell Park Comprehensive Cancer Center
  • Muzaffar Qazilbash, MD of MD Anderson Cancer Center
  • Paul Richardson, MD of Dana-Farber Cancer Institute

Want more?

We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

Other HealthTree University Classes:

  1. Myeloma Basics Part 1
  2. Myeloma Basics Part 2
  3. Myeloma Basics Part 3
  4. Building Your HealthCare Team
  5. Becoming an Empowered Patient
  6. Starting Myeloma Treatment
  7. Autologous Stem Cell Transplant (ASCT)
  8. Precursor Conditions
  9. Relapsed and Refractory MM Treatment
  10. Myeloma Bone Disease
  11. Testing, Monitoring MM Markers
  12. [BETA] Multiple Myeloma Genetics and Precision Medicine
  13. Classes of Myeloma Drugs
  14. [BETA] COVID-19 and Multiple Myeloma

 

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811